Parallax Volatility Advisers
AVNS

Parallax Volatility Advisers’s Avanos Medical AVNS Stock Holding History

Parallax Volatility Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,528
Closed -$433K – 4365
2014
Q4 		$433K Buy
+9,528
New +$374K ﹤0.01% 2168

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parallax Volatility Advisers's AVNS Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 14,480 shares — an estimated $992K sold.

Parallax Volatility Advisers first reported a position in AVNS in Q4 2014 and held it in 3 quarters. The position peaked at $992K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 14,480 Avanos Medical shares in Q4 2018, an estimated $992K.
  • Parallax Volatility Advisers first reported a position in Avanos Medical in Q4 2014 and held it in 3 quarters.
  • Parallax Volatility Advisers's Avanos Medical position peaked at $992K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.